Production (Stage)
Biohaven Ltd.
BHVN
$14.74
-$0.32-2.13%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.64% | -16.56% | 49.87% | -78.14% | -24.00% |
| Total Depreciation and Amortization | -8.74% | 23.42% | 2.05% | 35.13% | -23.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 198.51% | 664.31% | -102.01% | 248.03% | 35.71% |
| Change in Net Operating Assets | 27.43% | -129.32% | 188.02% | -190.99% | 393.89% |
| Cash from Operations | 3.29% | -20.86% | 15.81% | -63.49% | 10.66% |
| Capital Expenditure | -840.82% | 91.98% | 79.28% | -570.23% | 6.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 288.69% | 5.56% | 2.31% | -378.70% | 1,089.55% |
| Cash from Investing | 288.05% | 6.13% | 4.63% | -387.77% | 969.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.87% | 270.33% | -75.86% | 14,258.47% | -99.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -347.43% | -16.48% | 293.93% | 145.44% |
| Cash from Financing | -99.86% | 239.47% | -74.97% | 9,281.33% | -98.60% |
| Foreign Exchange rate Adjustments | -73.86% | -- | 100.00% | -16.67% | 98.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.99% | 109.41% | -378.58% | 184.96% | -151.68% |